Suppr超能文献

特发性肺纤维化的临床评估。

Clinical evaluation on idiopathic pulmonary fibrosis.

机构信息

Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Mar 28;46(3):309-315. doi: 10.11817/j.issn.1672-7347.2021.190402.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic fatal pulmonary disease characterized by complex illness condition. There is no effective treatment at present except lung transplantation. The comprehensive evaluation is helpful for the management of patients with IPF in hierarchical stages. Therefore, it is very important to evaluate IPF by various independent factors. At present, the commonly used methods for clinical evaluation on IPF include assessment of health-related quality of life, assessment of physiological function, assessment of imaging, assessment of laboratory examination, and multi-dimensional assessment system. However, there are different advantages and disadvantages on diverse evaluation methods for the evaluation of IPF.

摘要

特发性肺纤维化(IPF)是一种慢性致命性肺部疾病,其特征为复杂的疾病状况。目前除肺移植外尚无有效治疗方法。综合评估有助于对 IPF 患者进行分层管理。因此,通过各种独立因素对 IPF 进行评估非常重要。目前,临床上常用于评估 IPF 的方法包括健康相关生活质量评估、生理功能评估、影像学评估、实验室检查评估和多维评估系统。然而,对于 IPF 的评估,不同的评估方法各有优缺点。

相似文献

1
Clinical evaluation on idiopathic pulmonary fibrosis.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Mar 28;46(3):309-315. doi: 10.11817/j.issn.1672-7347.2021.190402.
2
Assessment and Management of Cough in Idiopathic Pulmonary Fibrosis: A Narrative Review.
Lung. 2023 Dec;201(6):531-544. doi: 10.1007/s00408-023-00653-3. Epub 2023 Nov 7.
3
Idiopathic pulmonary fibrosis: Current and future treatment.
Clin Respir J. 2022 Feb;16(2):84-96. doi: 10.1111/crj.13466. Epub 2022 Jan 10.
4
Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue.
Eur Respir Rev. 2019 Oct 1;28(153). doi: 10.1183/16000617.0044-2019. Print 2019 Sep 30.
5
Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.
Lung. 2016 Apr;194(2):227-34. doi: 10.1007/s00408-016-9850-y. Epub 2016 Feb 9.
6
[Research Progress in the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2020 Aug 20;23(8):695-700. doi: 10.3779/j.issn.1009-3419.2020.102.23.
8
Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620910092. doi: 10.1177/1753466620910092.
9
Idiopathic pulmonary fibrosis: early detection and referral.
Respir Med. 2014 Jun;108(6):819-29. doi: 10.1016/j.rmed.2014.03.008. Epub 2014 Apr 4.
10
Multi-dimensional indices to stage idiopathic pulmonary fibrosis: a systematic review.
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):8-18.

引用本文的文献

1
Mitigation of Oxidative Stress in Idiopathic Pulmonary Fibrosis Through Exosome-Mediated Therapies.
Int J Nanomedicine. 2024 Jun 19;19:6161-6176. doi: 10.2147/IJN.S453739. eCollection 2024.
2
Efficacy of Qingfei oral liquid for idiopathic pulmonary fibrosis in rats and related network pharmacology study.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Feb 25;51(1):53-61. doi: 10.3724/zdxbyxb-2021-0203.

本文引用的文献

1
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
2
Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
Lung. 2018 Dec;196(6):707-713. doi: 10.1007/s00408-018-0152-4. Epub 2018 Aug 27.
4
Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.
Am J Respir Crit Care Med. 2019 Jan 1;199(1):12-21. doi: 10.1164/rccm.201803-0444PP.
5
[A review of severity staging classiffication system for idiopathic pulmonary fibrosis].
Zhonghua Jie He He Hu Xi Za Zhi. 2018 May 12;41(5):355-358. doi: 10.3760/cma.j.issn.1001-0939.2018.05.010.
6
Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Respirology. 2018 Aug;23(8):764-770. doi: 10.1111/resp.13294. Epub 2018 Mar 24.
7
mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis.
ERJ Open Res. 2017 Dec 14;3(4). doi: 10.1183/23120541.00084-2017. eCollection 2017 Oct.
8
Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up.
Radiology. 2017 Oct;285(1):270-278. doi: 10.1148/radiol.2017161177. Epub 2017 May 10.
9
The St. George's Respiratory Questionnaire as a prognostic factor in IPF.
Respir Res. 2017 Jan 17;18(1):18. doi: 10.1186/s12931-017-0503-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验